X4 Pharmaceuticals to Participate in the Stifel 2024 Healthcare Conference
X4 Pharmaceuticals (Nasdaq: XFOR), focused on rare immune system diseases, announced its participation in the Stifel 2024 Healthcare Conference in New York. The company will engage in a fireside chat on Monday, November 18, 2024, at 4:10 PM ET at the Lotte New York Palace. A live webcast will be available through X4's website's investor section, with a replay accessible after the event. The company will also be available for one-on-one meetings with investors, which can be arranged through Stifel representatives.
X4 Pharmaceuticals (Nasdaq: XFOR), specializzata in malattie rare del sistema immunitario, ha annunciato la sua partecipazione alla Stifel 2024 Healthcare Conference a New York. L'azienda parteciperà a una chiacchierata informale lunedì 18 novembre 2024, alle 16:10 ET presso il Lotte New York Palace. Sarà disponibile una diretta streaming nella sezione dedicata agli investitori del sito web di X4, con una registrazione accessibile dopo l'evento. L'azienda sarà inoltre disponibile per incontri uno a uno con gli investitori, che possono essere organizzati tramite i rappresentanti di Stifel.
X4 Pharmaceuticals (Nasdaq: XFOR), centrada en enfermedades raras del sistema inmunológico, anunció su participación en la Stifel 2024 Healthcare Conference en Nueva York. La empresa tendrá una charla informal el lunes 18 de noviembre de 2024, a las 4:10 PM ET en el Lotte New York Palace. Habrá una transmisión en vivo disponible a través de la sección de inversores del sitio web de X4, con una repetición accesible después del evento. La empresa también estará disponible para reuniones personales con inversores, que se pueden organizar a través de los representantes de Stifel.
X4 Pharmaceuticals (Nasdaq: XFOR), 희귀 면역 질환에 중점을 두고 있는 회사가 뉴욕에서 열리는 Stifel 2024 Healthcare Conference에 참여할 것이라고 발표했습니다. 이 회사는 2024년 11월 18일, 오후 4:10 ET에 Lotte New York Palace에서 화로 앞 인터뷰에 참여할 예정입니다. X4 웹사이트의 투자자 섹션을 통해 생중계가 제공되며, 이벤트 후 다시 볼 수 있는 녹화도 이용 가능합니다. 또한 이 회사는 투자자와의 일대일 미팅을 위해 Stifel 대표를 통해 조정 가능합니다.
X4 Pharmaceuticals (Nasdaq: XFOR), axée sur les maladies rares du système immunitaire, a annoncé sa participation à la Stifel 2024 Healthcare Conference à New York. L'entreprise participera à une discussion informelle le lundi 18 novembre 2024, à 16h10 ET au Lotte New York Palace. Une diffusion en direct sera disponible sur la section investisseurs du site de X4, avec une rediffusion accessible après l'événement. L'entreprise sera également disponible pour des réunions individuelles avec des investisseurs, qui peuvent être organisées par l'intermédiaire des représentants de Stifel.
X4 Pharmaceuticals (Nasdaq: XFOR), das sich auf seltene Erkrankungen des Immunsystems spezialisiert hat, kündigte seine Teilnahme an der Stifel 2024 Healthcare Conference in New York an. Das Unternehmen wird am Montag, den 18. November 2024, um 16:10 Uhr ET in einem informellen Gespräch im Lotte New York Palace teilnehmen. Eine Live-Übertragung wird über den Investorenbereich der Website von X4 verfügbar sein, mit einer Aufzeichnung, die nach der Veranstaltung zugänglich ist. Das Unternehmen wird auch für persönliche Gespräche mit Investoren zur Verfügung stehen, die über die Vertreter von Stifel organisiert werden können.
- None.
- None.
BOSTON, Nov. 14, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that management will participate in the Stifel 2024 Healthcare Conference, taking place in New York, NY on November 18-19, 2024.
| Stifel 2024 Healthcare Conference | |
| Date: | Monday, November 18, 2024 |
| Time: | 4:10PM ET |
| Format: | Fireside Chat |
| Location: | Lotte New York Palace, New York |
| Webcast Link | |
A link for this live webcast will also be accessible through the “events & presentations” page in the investors section of X4 Pharmaceuticals’ website. After the conclusion of the conference, a webcast replay will be available through the same link.
The Company will be available for one-on-one meetings during this conference. Interested investors should contact their Stifel representative to request meetings.
About X4 Pharmaceuticals
X4 is delivering progress for patients by developing and commercializing innovative therapies for those with rare diseases of the immune system and significant unmet needs. Leveraging our expertise in CXCR4 and immune system biology, we have successfully developed mavorixafor, which has received U.S. approval as XOLREMDI® (mavorixafor) capsules in its first indication. We are also evaluating the use of mavorixafor in additional potential indications. X4 corporate headquarters are in Boston, Massachusetts and our research center of excellence is in Vienna, Austria. For more information, please visit our website at www.x4pharma.com.
Company Contact:
José Juves
Head of Corporate & Patient Affairs
jose.juves@x4pharma.com
Investor Contact:
Daniel Ferry
Managing Director, LifeSci Advisors
daniel@lifesciadvisors.com
(617) 430-7576
FAQ
When is X4 Pharmaceuticals (XFOR) presenting at the Stifel 2024 Healthcare Conference?
Where can investors watch X4 Pharmaceuticals' (XFOR) Stifel Conference presentation?
How can investors schedule one-on-one meetings with X4 Pharmaceuticals (XFOR) at the Stifel Conference?
Where is the Stifel 2024 Healthcare Conference being held for X4 Pharmaceuticals (XFOR)?
